339 related articles for article (PubMed ID: 24962990)
1. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding.
Agyeman A; Jha BK; Mazumdar T; Houghton JA
Oncotarget; 2014 Jun; 5(12):4492-503. PubMed ID: 24962990
[TBL] [Abstract][Full Text] [Related]
2. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
[TBL] [Abstract][Full Text] [Related]
3. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.
Mazumdar T; Devecchio J; Agyeman A; Shi T; Houghton JA
Cancer Res; 2011 Sep; 71(17):5904-14. PubMed ID: 21747117
[TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA damage following termination of Hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer.
Agyeman A; Mazumdar T; Houghton JA
Oncotarget; 2012 Aug; 3(8):854-68. PubMed ID: 23097684
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling drives cellular survival in human colon carcinoma cells.
Mazumdar T; DeVecchio J; Shi T; Jones J; Agyeman A; Houghton JA
Cancer Res; 2011 Feb; 71(3):1092-102. PubMed ID: 21135115
[TBL] [Abstract][Full Text] [Related]
6. Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing.
Zhang R; Wu J; Ferrandon S; Glowacki KJ; Houghton JA
Oncotarget; 2016 Dec; 7(49):80190-80207. PubMed ID: 27863397
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.
Mazumdar T; Sandhu R; Qadan M; DeVecchio J; Magloire V; Agyeman A; Li B; Houghton JA
PLoS One; 2013; 8(9):e75253. PubMed ID: 24086482
[TBL] [Abstract][Full Text] [Related]
8. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy.
Réda J; Vachtenheim J; Vlčková K; Horák P; Vachtenheim J; Ondrušová L
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201866
[TBL] [Abstract][Full Text] [Related]
9. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
[TBL] [Abstract][Full Text] [Related]
10. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
Huang L; Walter V; Hayes DN; Onaitis M
Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
[TBL] [Abstract][Full Text] [Related]
12. Gant61 ameliorates CCl
Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling.
Harada K; Ohashi R; Naito K; Kanki K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354204
[TBL] [Abstract][Full Text] [Related]
14. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
15. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
16. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
[TBL] [Abstract][Full Text] [Related]
17. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
18. Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth.
Maresca L; Crivaro E; Migliorini F; Anichini G; Giammona A; Pepe S; Poggialini F; Vagaggini C; Giannini G; Sestini S; Borgognoni L; Lapucci A; Dreassi E; Taddei M; Manetti F; Petricci E; Stecca B
Pharmacol Res; 2023 Sep; 195():106858. PubMed ID: 37473878
[TBL] [Abstract][Full Text] [Related]
19. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
Hu MC; Mo R; Bhella S; Wilson CW; Chuang PT; Hui CC; Rosenblum ND
Development; 2006 Feb; 133(3):569-78. PubMed ID: 16396903
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
